News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
281,659 Results
Type
Article (14903)
Company Profile (299)
Press Release (266451)
Multimedia
Podcasts (78)
Webinars (11)
Section
Business (79835)
Career Advice (162)
Deals (13338)
Drug Delivery (39)
Drug Development (50712)
Employer Resources (31)
FDA (5838)
Job Trends (5179)
News (145095)
Policy (10077)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Standard (2)
Academia (920)
Accelerated approval (19)
Adcomms (14)
Allergies (81)
Alliances (21761)
ALS (125)
Alzheimer's disease (1032)
Antibody-drug conjugate (ADC) (241)
Approvals (6035)
Artificial intelligence (259)
Autoimmune disease (114)
Automation (9)
Bankruptcy (105)
Best Places to Work (4573)
BIOSECURE Act (6)
Biosimilars (100)
Biotechnology (230)
Bladder cancer (101)
Brain cancer (45)
Breast cancer (344)
Cancer (3132)
Cardiovascular disease (237)
Career advice (147)
Career pathing (7)
CAR-T (220)
CDC (5)
Cell therapy (566)
Cervical cancer (14)
Clinical research (43686)
Collaboration (1152)
Company closure (2)
Compensation (596)
Complete response letters (39)
COVID-19 (1100)
CRISPR (86)
C-suite (553)
Cystic fibrosis (112)
Data (4328)
Denatured (15)
Depression (92)
Diabetes (257)
Diagnostics (1379)
Digital health (10)
Diversity (5)
Diversity, equity & inclusion (9)
Drug discovery (188)
Drug pricing (48)
Drug shortages (3)
Duchenne muscular dystrophy (216)
Earnings (31646)
Editorial (25)
Employer branding (4)
Employer resources (29)
Events (51668)
Executive appointments (622)
FDA (7594)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (10)
Frontotemporal dementia (22)
Funding (984)
Gene editing (182)
Generative AI (21)
Gene therapy (490)
GLP-1 (504)
Government (1149)
Grass and pollen (3)
Guidances (166)
Healthcare (6611)
HIV (18)
Huntington's disease (43)
IgA nephropathy (74)
Immunology and inflammation (190)
Immuno-oncology (40)
Indications (66)
Infectious disease (1205)
Inflammatory bowel disease (156)
Inflation Reduction Act (10)
Influenza (38)
Intellectual property (166)
Interviews (18)
IPO (7345)
IRA (12)
Job creations (867)
Job search strategy (129)
JPM (40)
Kidney cancer (9)
Labor market (22)
Layoffs (243)
Leadership (9)
Legal (1400)
Liver cancer (41)
Longevity (11)
Lung cancer (421)
Lymphoma (249)
Machine learning (24)
Management (7)
Manufacturing (376)
MASH (130)
Medical device (2662)
Medtech (2671)
Mergers & acquisitions (6617)
Metabolic disorders (727)
Multiple sclerosis (104)
NASH (13)
Neurodegenerative disease (232)
Neuropsychiatric disorders (70)
Neuroscience (1955)
Neurotech (1)
NextGen: Class of 2026 (2034)
Non-profit (865)
Now hiring (30)
Obesity (329)
Opinion (125)
Ovarian cancer (132)
Pain (102)
Pancreatic cancer (161)
Parkinson's disease (232)
Partnered (12)
Patents (301)
Patient recruitment (331)
Peanut (43)
People (26657)
Pharmaceutical (44)
Pharmacy benefit managers (6)
Phase 1 (15477)
Phase 2 (20292)
Phase 3 (12833)
Pipeline (3267)
Policy (90)
Postmarket research (853)
Preclinical (6535)
Press Release (30)
Prostate cancer (145)
Psychedelics (50)
Radiopharmaceuticals (238)
Rare diseases (652)
Real estate (1448)
Recruiting (12)
Regulatory (9906)
Reports (19)
Research institute (971)
Resumes & cover letters (18)
Rett syndrome (24)
RNA editing (21)
RSV (16)
Schizophrenia (123)
Series A (183)
Series B (137)
Service/supplier (1)
Sickle cell disease (77)
Special edition (18)
Spinal muscular atrophy (119)
Sponsored (15)
Startups (2005)
State (1)
Stomach cancer (5)
Supply chain (32)
Tariffs (18)
The Weekly (62)
Vaccines (334)
Venture capital (69)
Weight loss (173)
Women's health (25)
Worklife (2)
Date
Today (48)
Last 7 days (330)
Last 30 days (1175)
Last 365 days (17847)
2026 (1712)
2025 (18101)
2024 (20548)
2023 (22421)
2022 (26831)
2021 (27809)
2020 (23358)
2019 (16225)
2018 (11738)
2017 (13745)
2016 (11841)
2015 (14350)
2014 (10392)
2013 (7485)
2012 (7532)
2011 (7614)
2010 (7428)
Location
Africa (154)
Alabama (65)
Alaska (2)
Arizona (71)
Arkansas (5)
Asia (18256)
Australia (3111)
California (7082)
Canada (1839)
China (775)
Colorado (247)
Connecticut (252)
Delaware (235)
Europe (39179)
Florida (904)
Georgia (209)
Hawaii (2)
Idaho (17)
Illinois (395)
India (35)
Indiana (161)
Iowa (8)
Japan (224)
Kansas (80)
Kentucky (9)
Louisiana (7)
Maine (11)
Maryland (736)
Massachusetts (5590)
Michigan (110)
Minnesota (247)
Mississippi (3)
Missouri (32)
Montana (16)
Nebraska (5)
Nevada (32)
New Hampshire (21)
New Jersey (1649)
New Mexico (13)
New York (1763)
North Carolina (827)
North Dakota (6)
Northern California (3480)
Ohio (178)
Oklahoma (11)
Oregon (24)
Pennsylvania (1280)
Puerto Rico (9)
Rhode Island (25)
South America (215)
South Carolina (9)
Southern California (2808)
Tennessee (40)
Texas (907)
United States (23359)
Utah (96)
Virginia (136)
Washington D.C. (37)
Washington State (592)
West Virginia (1)
Wisconsin (45)
281,659 Results for "tenaya therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Tenaya Therapeutics Announces 2026 Strategic Priorities and Anticipated Milestones
January 9, 2026
·
11 min read
Press Releases
Tenaya Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update
November 10, 2025
·
13 min read
Press Releases
Tenaya Therapeutics to Participate in Upcoming October 2025 Investor Conferences
October 3, 2025
·
2 min read
Press Releases
Tenaya Therapeutics to Participate in H.C. Wainwright Genetic Medicines Virtual Conference
October 9, 2025
·
1 min read
Press Releases
Tenaya Therapeutics Announces Rapid Resolution and Lifting of Clinical Hold for MyPEAK-1™ Phase 1b/2a Clinical Trial of TN-201 Gene Therapy
December 12, 2025
·
7 min read
Layoffs
Tenaya Slashes a Third of Workforce To Fund Development of Cardio Gene Therapies
The layoffs will take place throughout 2025 and will mostly affect Tenaya’s research and manufacturing operations. The company is continuing to test its hypertrophic cardiomyopathy gene therapy.
April 1, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Tenaya Therapeutics to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference
September 3, 2025
·
1 min read
Press Releases
Tenaya Therapeutics Reports Positive Interim Data from Cohort 1 of RIDGE™-1 Phase 1b/2 Clinical Trial of TN-401 Gene Therapy for Adults with PKP2-associated ARVC
December 12, 2025
·
11 min read
Press Releases
Tenaya Therapeutics Announces New Clinical Data for TN-201 Gene Therapy will be Featured in Late-Breaking Presentation at the American Heart Association Scientific Sessions 2025
November 4, 2025
·
4 min read
Press Releases
Tenaya Therapeutics to Participate in the Canaccord Genuity 45th Annual Growth Conference
August 8, 2025
·
1 min read
1 of 28,166
Next
